Vice-President, Global R&D Epidemiology, Janssen Pharmaceutical Companies of Johnson & Johnson
Paul Stang is the vice-president of global epidemiology at Janssen Research and Development, leading a group of more than 30 researchers who support observational research across Johnson & Johnson. Prior to joining J&J, Stang was a vice-president at Cerner Corporation, which he joined after co-founding and serving as the chief scientific officer of Galt Associates, a healthcare consulting and informatics start-up that was purchased by Cerner. Previously, he served as a research investigator for the Observational Medical Outcomes Partnership, a public-private partnership. He has published widely in epidemiology, health outcomes, productivity, and communications. He serves as a reviewer for a number of journals and is a member of a number of research consortia, governance, and scientific advisory boards.